Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexibuprofen topical gel versus placebo for acute soft-tissue contusions
2025-524451-31-00Phase 3Authorised
- Sponsor
- Aponia Laboratories
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in bruise comparing Dexibuprofen topical gel 5% with Placebo gel (2 arms). Primary endpoint: Change from baseline / pain intensity difference of pain on movement at 24 hours. Planned start Oct 2026; status: authorised.
02
Drugs
dexibuprofen
03
Conditions
bruise
Beyond the preview
Go deeper on 2025-524451-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524451-31-00.